Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that the Company has begun the limited market release of Trinity®
Evolution™ in collaboration with the Musculoskeletal
Transplant Foundation (MTF). Trinity Evolution is a stem cell-based bone
growth matrix designed to advance the surgical use of allografts by
providing characteristics similar to an autograft in spinal and
orthopedic procedures.
“We are extremely pleased to announce that we have begun to make Trinity
Evolution available to our surgeon customers. The initial feedback we
have received on Trinity Evolution has been extraordinarily positive,
and we look forward to our full market release by July 1, 2009,” said
Alan Milinazzo, President and CEO of Orthofix International.
Dr. Steve Yocom completed the first procedure using Trinity Evolution on
April 28th. The 46-year-old patient underwent a lumbar spine
fusion procedure at Cooper University Hospital in Camden, NJ. Since
commencing our limited release, Trinity Evolution has been implanted in
a variety of spinal and orthopedic procedures by several leading
surgeons around the country, including Dr. Michael Zindrick, Dr. Mark
Lorenz, Dr. Christopher Bibbo, Dr. Daniel Lee and Dr. Jamie Gottlieb.
“Trinity Evolution is an excellent new tissue form that should be of
great benefit to patients and the doctors who serve them,” said Bruce
Stroever, President and CEO of MTF.
Trinity Evolution is used by surgeons to facilitate bone fusion, and
will be marketed exclusively by Orthofix Spinal Implants and Orthofix
Orthopedics. MTF is responsible for the recovery of donor tissue, the
processing of the bone growth matrix, and for the fulfilment of orders
received.
Orthofix anticipates completing the full market release of Trinity
Evolution by July 1st of this year.
About Orthofix
Orthofix International, N.V., a global medical device company, offers a
broad line of minimally invasive surgical, and non-surgical, products
for the spine, orthopedic, and sports medicine market sectors that
address the lifelong bone-and-joint health needs of patients of all
ages–helping them achieve a more active and mobile lifestyle. Orthofix’s
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix’s sales representatives and its subsidiaries,
including BREG, Inc. and Blackstone Medical, Inc., and via partnerships
with other leading orthopedic product companies.
